Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAPROXEN\SUMATRIPTAN vs NARATRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAPROXEN\SUMATRIPTAN vs NARATRIPTAN: Safety Overview

Metric NAPROXEN\SUMATRIPTAN NARATRIPTAN
Total FAERS Reports 233 526
Deaths Reported 15 9
Death Rate 6.4% 1.7%
Hospitalizations 14 102
Average Patient Age 47.8 yrs 49.2 yrs
% Female Patients 84.5% 90.0%
FDA Approval Date N/A Apr 22, 2011
Manufacturer N/A Hikma Pharmaceuticals USA Inc.
Route N/A ORAL
Marketing Status N/A Discontinued